Double-blind Placebo-Controlled Randomised Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenon After Renal Tranplantation : Effect on Graft Function at 3 Months.
Phase of Trial: Phase III
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Eplerenone (Primary)
- Indications Delayed graft function
- Focus Registrational; Therapeutic Use
- Acronyms EPURE TRANSPLANT
- 21 Jun 2017 Planned End Date changed from 1 May 2030 to 1 Jul 2030.
- 21 Jun 2017 Planned primary completion date changed from 1 Aug 2020 to 1 Jul 2020.
- 21 Jun 2017 Status changed from not yet recruiting to recruiting.